The fight against coronavirus will be won through vaccine and drugs, VK Paul, member, Niti Aayog said on Thursday in a press briefing on the development of drugs, vaccines and technologies for testing during COVID-19 pandemic.
The fight against #Coronavirus will be won through vaccine and drugs. Our country’s science and technology institutions and pharma industry are very strong: VK Paul, Member- Health, #NitiAayog https://t.co/Ljy8IOtBhz pic.twitter.com/N3uNvbtxRR
— NewsMobile (@NewsMobileIndia) May 28, 2020
Key takeaways from the presser:
– The fight against Coronavirus will be won through vaccine and drugs. Our country’s science and technology institutions and pharma industry are very strong: VK Paul, Member- Health, Niti Aayog
– We are very proud of our strong scientific base, strong pharmaceutical industry, both these dimensions are very strong. All our scientific institutes are fighting COVID-19: NITI Aayog
– Designing new drugs is a big challenge. In India, CSIR and AICTE have started a high-end hackathon where students are trained in drug designing: Dr K Vijayraghavan, principal scientific advisor to GoI, co-chair task force on scientific development on COVID-19
– 5 important things to be kept in mind for the prevention of #COVID19 before vaccine arrives: PM’s Scientific Advisor
▶️Proper Hygiene
▶️Decontamination of surfaces
▶️Physical Distancing
▶️Tracking
▶️Testing
– When the vaccine is made it will not be a switch. Everybody, from the youngest to oldest will need a vaccine.
ALSO READ: COVID-19 LIVE | India records 6,566 new positive cases, 194 deaths in last 24 hours
– A vaccine is given to the normal population, not sick people; hence it is necessary that it is properly tested and its quality and safety are ensured:
– There are about 30 groups in India, big industry to individual academics, are trying got develop a vaccine: PM’s Scientific Advisor
There are about a total of 30 groups in India, big industry to individual academics, who are trying got develop vaccines, of around 20 are keeping a good pace: Principal Scientific Advisor (PSA) to the Government of India Prof K. Vijay Raghavan pic.twitter.com/GPTUc00dXk
— NewsMobile (@NewsMobileIndia) May 28, 2020
– India’s vaccine manufacturing is world-class. India is also one of the world’s biggest generics manufacturers. Our vaccine companies are now also into vaccine development and R&D, not just manufacturing: PM’s Scientific Advisor on COVID vaccine development
– No Indian companies or collaborations are in the clinical trial stage for vaccines yet: Dr K Vijayraghavan,
– A vaccine is not a switch that it will be available to everyone from Day 1. In this disease, everybody will need it. So access a big challenge: PM’s Scientific Advisor
– A drug designed to attack the virus has to attack only its unique parts so that it doesn’t start affecting our body cells.